GLP-1(9-36)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GLP-1(9-36), covering 2013-01-23 to 2013-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Dose-response Study of Exendin-9,39 on Glucose Metabolism [Phase 1]